|
gptkbp:instanceOf
|
gptkb:Hallucinogen
|
|
gptkbp:actsOn
|
gptkb:serotonin_receptor_agonist
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:CASNumber
|
520-52-5
|
|
gptkbp:category
|
gptkb:psychedelic_tryptamine
gptkb:alkaloid
gptkb:serotonin_receptor_agonist
|
|
gptkbp:chemicalFormula
|
C12H16N2O
|
|
gptkbp:color
|
white to off-white
|
|
gptkbp:degradedBy
|
oxygen
heat
light
|
|
gptkbp:discoveredBy
|
gptkb:Albert_Hofmann
|
|
gptkbp:discoveredIn
|
1958
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:foundIn
|
psilocybin mushrooms
|
|
gptkbp:halfLife
|
1–3 hours
|
|
gptkbp:hasInChIKey
|
KZPZGVMLZUAESH-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
CN(C)CCC1=CNC2=CC(=O)C=CC2=C1
|
|
gptkbp:IUPACName
|
4-hydroxy-N,N-dimethyltryptamine
|
|
gptkbp:legal_status_in_UK
|
Class A drug
|
|
gptkbp:legalStatus
|
Schedule I controlled substance
|
|
gptkbp:meltingPoint
|
173–176 °C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:metabolite_of
|
psilocybin
|
|
gptkbp:molecularWeight
|
204.27 g/mol
|
|
gptkbp:pharmacological_effect
|
mystical experiences
euphoria
hallucinations
altered perception
|
|
gptkbp:PubChem_CID
|
10624
10186
CHEMBL391
|
|
gptkbp:relatedTo
|
gptkb:DMT
gptkb:bufotenin
psilocybin
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
insufflation
|
|
gptkbp:solubility
|
slightly soluble in water
soluble in ethanol
soluble in chloroform
soluble in methanol
|
|
gptkbp:UNII
|
4UFN936YRU
|
|
gptkbp:bfsParent
|
gptkb:Magic_Truffle
gptkb:Magic_Mushrooms
gptkb:Psilocybe_mexicana
gptkb:Shrooms
gptkb:Magic_mushrooms
gptkb:Spids_Nøgenhat
gptkb:Psilocybin_Mushrooms
gptkb:SB_519
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Psilocin
|